The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 1007-1013

  Inoue, M ^a   Sakaguchi, J ^a   Sasagawa, T ^a   Tango, M ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KANAZAWA MEDICAL CENTER   (Japan)

Author keywords

Cervical cancer screening; Cytology; HPV DNA test

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SCREENING; CLINICAL TRIAL; COHORT ANALYSIS; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA MICROARRAY; EVALUATION; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROCHIP ANALYSIS; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SCREENING TEST; SERODIAGNOSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; VIRUS VIRULENCE; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHILD; COHORT STUDIES; DNA, VIRAL; FEMALE; HUMANS; JAPAN; MASS SCREENING; MICROARRAY ANALYSIS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33745086134     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00460.x     Document Type: Article

References (19)

1. Kuroishi T Hirose K Tominaga S. Evaluation of the efficacy of mass-screening for uterine cancer in Japan. Jpn J Cancer Res (Gann) 1986 77 : 399 405.
2. Ko N Kuroishi T Tominaga T. Evaluation of the usefulness of cervical cancer screening-relation between mortality and participation rate. Nippon Koshueiseishi 1994 39 : 784 8.
3. Health and Welfare Statistics Association. Annual mortality trends by leading causes of death in Japan (1899-2003). J Health Welfare Stat 2005 52 ( Suppl 362 385.
4. Matsunaga G. Cost-effectiveness analysis of mass screening for cervical cancer in Japan. J Epidemiol 1997 7 : 1 7.
5. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002 2 : 342 50.
6. Bosch FX Lorincz A Munoz N Meijer CJ Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002 55 : 244 65.
7. Sherman ME Lorincz AT Scott DR et al. Baseline cytology, human papillomavirus testing and risk for cervical neoplasia: A 10-year cohort analysis. J Natl Cancer Inst 2003 95 : 46 52.
8. Petry KU Menton S Menton M et al. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer 2003 88 : 1570 7.
9. Wright TC Jr. Schiffman M Solomon Diane D et al. Interim guidance for the use of human papillomavirus DNA testing as a adjuvant to cervical cytology for screening. Obstet Gynecol 2004 103 : 304 9.
10. Ishikawa cervical cancer committee. An annual report of cancer screening. Cancer screening program committee of Ishikawa. 2004, Ishikawa, Japan.
11. Training program committee. Classification of cytology in guideline for cervical cancer screening. Jpn Ass Obst and Gyn 1997 52 70.
12. Sasagawa T Basha W Yamazaki H Inoue M. High-risk and multiple HPV infection associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 2001 10 : 45 52.
13. Clavel C Masura M Bory JP et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions. A study of 7932 women. Br J Cancer 2001 84 : 1616 23.
14. Cuzik J Szarewski A Cubie H et al. Management of women who test positive for high-risk types of human papillomavirus: HART study. Lancet 2003 362 : 1871 6.
15. An HJ Cho NH Lee SY et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus genotypes with the HPV DNA chip microarray method. Cancer 2003 97 : 1672 80.
16. Asato T Maehama T Nagai Y Kanazawa K Uezato H Kariya K. A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J Infect Dis 2004 189 : 1829 32.
17. An HJ Kim IS Kim DW et al. Prevalence of human papillomavirus DNA in various histological subtype of cervical adenocarcinoma: a population-based study. Mod Pathol 2004 22 : 167 75.
18. Munoz N Bosch X Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003 348 : 518 27.
19. Hwang TS Jeong JK Park M Han HS Choi HK Park TS. Detection and typing of HPV genotypes in various cervical lesions by oligonucleotide microarray. Gynecol Oncol 2003 90 : 51 6.